logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
Y

Youling Gong

Sichuan University
H指数:28
被引数:3,330

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Low-dose radiotherapy concurrent with atezolizumab and chemotherapy as first-line treatment for extensive-stage small-cell lung cancer: 3-year follow-up of a multicenter, single-arm, phase 2 trial (MATCH)

低剂量放射治疗与阿替利珠单抗和化疗联合作为广泛期小细胞肺癌的一线治疗方案：一项多中心、单臂、II期试验（MATCH）的3年随访研究

international journal of radiation oncology biology physics
IF0
2025-07-010
OA
Lin Zhou; Jianguo Sun; Conghua Xie; Kai Kang; Zhuoran Yao; Youling Gong; Meijuan Huang; Hui Wang; Lin Wu; Zhiyong Yuan; Nan Bi; Min Fan; Yaping Xu; Yao Chen; You Lu
Preclinical study and phase II trial of adapting low-dose radiotherapy to immunotherapy in small cell lung cancer
MED
IF11.8
2024-10-013
OAAI
Wang, Hui; Yao, Zhuoran; Kang, Kai; Zhou, Lin; Xiu, Weigang; Sun, Jianguo; Xie, Conghua; Yu, Min; Li, Yanying; Zhang, Yan; Zheng, Yue; Lin, Guo; Pan, Xiangyu; Wu, Yijun; Luo, Ren; Wang, Laduona; Tang, Min; Liao, Shuangsi; Zhu, Jiang; Zhou, Xiaojuan; Zhang, Xuanwei; Xu, Yong; Liu, Yongmei; Peng, Feng; Wang, Jin; Xiang, Lisha; Yin, Limei; Deng, Lei; Huang, Meijuan; Gong, Youling; Zou, Bingwen; Wang, Hui; Wu, Lin; Yuan, Zhiyong; Bi, Nan; Fan, Min; Xu, Yaping; Tong, Ruizhan; Yi, Linglu; Gan, Lu; Xue, Jianxin; Mo, Xianming; Chen, Chong; Na, Feifei; Lu, You
Updated overall survival and circulating tumor DNA analysis of ensartinib for crizotinib-refractory ALK-positive NSCLC from a phase II study
CANCER COMMUNICATIONS
IF24.9
2024-02-291
OAAI
Zheng, Jing; Wang, Tao; Yang, Yunpeng; Huang, Jie; Feng, Jifeng; Zhuang, Wu; Chen, Jianhua; Zhao, Jun; Zhong, Wei; Zhao, Yanqiu; Zhang, Yiping; Song, Yong; Hu, Yi; Yu, Zhuang; Gong, Youling; Chen, Yuan; Ye, Feng; Zhang, Shucai; Cao, Lejie; Fan, Yun; Wu, Gang; Guo, Yubiao; Zhou, Chengzhi; Ma, Kewei; Fang, Jian; Feng, Weineng; Liu, Yunpeng; Zheng, Zhendong; Li, Gaofeng; Wang, Huijie; Cang, Shundong; Wu, Ning; Song, Wei; Liu, Xiaoqing; Zhao, Shijun; Ding, Lieming; Selvaggi, Giovanni; Wang, Yang; Xiao, Shanshan; Wang, Qian; Shen, Zhilin; Zhou, Jianya; Zhou, Jianying; Zhang, Li
Safety and Tolerability of Low-Dose Radiation and Stereotactic Body Radiotherapy plus Sintilimab for Treatment-Naive Stage IV PD-L1+ Non-Small Cell Lung Cancer Patients

低剂量放疗和立体定向放疗联合Sintilimab治疗初治IV期PD-L1非小细胞肺癌患者的安全性和耐受性

CLINICAL CANCER RESEARCH
IF10.2
2023-08-158
PRE
Zhou, Xiaojuan; Zhou, Laiyan; Yao, Zhuoran; Huang, Meijuan; Gong, Youling; Zou, Bingwen; Zhu, Jiang; Liu, Yongmei; Peng, Feng; Zhang, Yan; Yu, Min; Li, Yanying; Na, Feifei; Wu, Yijun; Kang, Kai; Xiu, Weigang; Zhang, Xuanwei; Zhou, Lin; Xu, Yong; Wang, Jin; Wang, Yan; Yang, Xue; Wu, Yuanjun; Li, Rui; Zhang, Yu; Yang, Zhenzhou; Zhou, Zhipeng; Bai, Jing; Yi, Xin; Tong, Ruizhan; Yin, Limei; Chen, Chong; Niedermann, Gabriele; Lu, You; Xue, Jianxin
Secondary Infections After Diagnosis of Severe Radiation Pneumonitis (SRP) Among Patients With Non-Small Cell Lung Cancer: Pathogen Distributions, Choice of Empirical Antibiotics, and the Value of Empirical Antifungal Treatment
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS
IF6.5
2022-01-017
PRE
Mei, Ting; Yang, Xuexi; Yu, Yang; Tian, Xiaoman; Deng, Qianyue; Xu, Yong; Zhou, Lin; Zhou, Xiaojuan; Liu, Yongmei; Zou, Bingwen; Xue, Jianxin; Quan, Min; Yan, Libo; Lu, You; Gong, Youling

研究方向

暂未获取到该数据
Y
You Lü
H 指数:51论文数:431被引数:1.2万
M
Meijuan Huang
H 指数:32论文数:312被引数:4,804
L
Lin Zhou
H 指数:42论文数:503被引数:6,968
X
Xiaojuan Zhou
H 指数:17论文数:131被引数:952
Y
Yong Xu
H 指数:22论文数:149被引数:1,754
J
Jianxin Xue
H 指数:35论文数:229被引数:4,370
Y
Yuquan Wei
H 指数:111论文数:1,207被引数:5.5万
J
Jiang Zhu
H 指数:25论文数:100被引数:2,683
Y
Yongsheng Wang
H 指数:33论文数:214被引数:4,793
B
Bingwen Zou
H 指数:28论文数:143被引数:3,578